Awareness of rheumatic heart disease

Lancet

Volumn 367, Issue 9528, 2006, Pages 2118-

  Steer, Andrew C ^a   Kado, Joseph ^b   Colquhoun, Samantha ^a   Noonan, Sara ^a   Babitu, Taraifina ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Fiji Ministry of Health   (Fiji)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE;

ANAMNESIS; ARTICLE; AWARENESS; CARDIOMEGALY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SCHOOL CHILD;

EID: 33745202072     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68934-4     Document Type: Article

References (5)

1. Carapetis J., Steer A., Mulholland E., and Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 5 (2005) 685-694
2. Carapetis J., and Currie B. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health 23 (1999) 159-163
3. Padmavati S. Rheumatic fever and rheumatic heart disease in developing countries. Bull World Health Organ 56 (1978) 543-550
4. Tompkins D., Boxerbaum B., and Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 45 (1972) 543-551
5. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation Geneva. WHO Technical report series (2004), World Health Organization, Geneva